Qualitek Labs Limited has officially notified the Bombay Stock Exchange regarding the non-applicability of Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the financial year ended 31st March, 2026. The communication, dated 6th April, 2026, was signed by Managing Director Antaryami Nayak and addresses the company's exemption from certain regulatory compliance requirements.

Regulatory Exemption Details

The exemption is grounded in Regulation 15(2) of the SEBI LODR Regulations, which provides specific relief to entities listed on SME exchanges. According to this provision, compliance with various corporate governance regulations is not mandatory for companies listed on SME platforms.

SME Platform Benefits

The company's listing on the BSE SME Platform provides comprehensive exemptions from multiple regulatory provisions. The exempted regulations include Regulations 17, 17A, 18, 19, 20, 21, 22, 23, 24, 24A, 25, 26, 26A, 27, and specific clauses of Regulation 46, along with Para C, D and E of Schedule V of the SEBI LODR Regulations.

Compliance Report Waiver

Under normal circumstances, Regulation 24A mandates the submission of an Annual Secretarial Compliance Report by a Practicing Company Secretary within 60 days from the end of the financial year. However, due to the SME listing exemption, Qualitek Labs Limited is not required to submit this report for the financial year ended 31st March, 2026.

Company Information

Qualitek Labs Limited operates with its registered office at 73, National Park, Lajpat Nagar IV, New Delhi, and maintains its corporate office at C-40, Sector 57, Noida. The company has been listed on the BSE SME Platform since 29th January, 2024, enabling it to benefit from the relaxed regulatory framework designed for small and medium enterprises.

Qualitek Labs Limited has filed its quarterly compliance certificate with the Bombay Stock Exchange under SEBI regulations for the quarter and financial year ended March 31, 2026. The submission, dated April 06, 2026, fulfills the company's regulatory obligations under the Securities and Exchange Board of India framework.

Regulatory Compliance Certificate

The company submitted its certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The certificate was provided by Skyline Financial Services Private Limited, which serves as the company's Registrar and Share Transfer Agent.

Dematerialization Status

The certificate confirms that no physical share certificates were received for dematerialization from depository participants during the quarter ended March 31, 2026. This indicates that the company's shares remain fully dematerialized with no pending conversion requests.

Shareholding Distribution

As of March 31, 2026, the company's shareholding pattern shows complete dematerialization across two major depositories:

Transaction Summary

The Registrar and Share Transfer Agent reported no share transfer transactions during the period. The summary shows:

• No transfer requests received or processed
• No transmission, transposition, or other corporate actions
• No requests rejected or pending
• All records updated in the register of members as of March 31, 2026

Corporate Information

Qualitek Labs Limited, incorporated with CIN L74999DL2018PLC334105, maintains its registered office at 73, National Park, Lajpat Nagar IV, New Delhi, and corporate office at C-40, Sector 57, Noida. The compliance certificate was signed by Managing Director Antaryami Nayak (DIN: 07232463) and authorized by Parveen Sharma from Skyline Financial Services Private Limited.